Baseline IGFBP - 3 as the Key Element to Predict Growth Response to Growth Hormone and IGF - 1 Therapy in Subjects with Non - GH Deficient Short Stature and IGF - 1 Deficiency.

Perez-Colon, Sheila; Lazareva, Oksana; Purushothaman, Radhika; Malik, Shahid; Ten, Svetlana; Bhangoo, Amrit

Perez-Colon, Sheila; Lazareva, Oksana; Purushothaman, Radhika; Malik, Shahid; Ten, Svetlana; Bhangoo, Amrit.

Afiliação

Perez-Colon S; Division of Pediatric Endocrinology at SUNY Downstate Medical Center and Kings County Hospital, Brooklyn, NY, USA.
Lazareva O; Pediatric Specialists of Virginia Fairfax, VA, USA.
Purushothaman R; Pediatric Endocrinology, Randall Children's Hospital, Portland OR, USA.
Malik S; Department of Medicine, NYU Woodhull Medical and Mental Health Center Brooklyn, NY, USA.
Ten S; Ten's Medical PC, Staten Island, NY, USA.
Bhangoo A; Pediatric Endocrinology Children's Hospital of Orange County, Orange CA, USA.

Int J Endocrinol Metab ; 16(3): e58928, 2018 Jul.

Article em En | MEDLINE | ID: mdl-30197657

Palavras-chave

Growth Hormone (GH); IGF - 1; IGFBP - 3; Short Stature; ΔIGF - 1

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Int J Endocrinol Metab Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google